M&A Deal Summary |
|
|---|---|
| Date | 2022-11-08 |
| Target | Cell IDx |
| Sector | Medical Products |
| Buyer(s) | Leica Biosystems Nussloch |
| Deal Type | Add-on Acquisition |
SEARCH BY
Leica Biosystems offers histopathology laboratories the most extensive product range with industry leading solutions for each workflow step, to enable the improvement of workflow efficiency and diagnostic confidence. The Company has manufacturing facilities in 7 countries, sales and service organizations in 19 countries, and an international network of dealers. Leica Biosystems is headquartered in Nussloch, Germany.
| DEAL STATS | # |
|---|---|
| Overall | 4 of 4 |
| Sector: Medical Products M&A | 3 of 3 |
| Type: Add-on Acquisition M&A Deals | 4 of 4 |
| State: California M&A | 2 of 2 |
| Country: United States M&A | 3 of 3 |
| Year: 2022 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-12-02 |
Devicor Medical Products
Pleasant Prairie, Wisconsin, United States Devicor Medical Products is a developing medical device businesses and products with a clinical preference. The Company owns the Mammotome breast care business which develops, manufactures and markets minimally invasive breast biopsy devices and accessories in over 40 countries worldwide. Devicor is led by CEO Tom Daulton. |
Buy | - |
